Balder, Jan-Willem
Kraaijeveld, Adriaan
Szymanski, Mariusz
van Laake, Linda
Hart, Einar
Voskuil, Michiel
Droogh, Joep
Ramjankhan, Faiz
van de Hoef, Tim
Hermens, Jeannine
van der Harst, Pim
Damman, Kevin
Lipsic, Erik
Pundziute, Gabija
Dickinson, Michael
Article History
Accepted: 28 April 2025
First Online: 3 July 2025
Conflict of interest
: A. Kraaijeveld has received speaker fees from Abiomed. Outside the scope of this work, he has received speaker fees from Inari, consultancy fees from Boston Scientific and Pulsecath, and an institutional research grant from Xenios AG. These fees were paid to the University Medical Center Utrecht. L. van Laake has received consultancy fees from Abbott, Medtronic, Vifor and Novartis, which were paid to the University Medical Centre Utrecht. L. van Laake, M. Voskuil and T. van de Hoef are associate editors of the Netherlands Heart Journal. T. van de Hoef received Institutional research grant from Philips. P. van der Harst is editor-in-chief of the Netherlands Heart Journal. K. Damman received speaker/consultancy fees from Abbott, Boehringer Ingelheim, FIRE1, Novartis, Astrazeneca, Echosense, Corteria. These fees were paid to the University Medical Center Groningen. E. Lipsic receiver Institutional Educational Grant from Abbott Medical. J.-W. Balder, M. Szymanski, E. Hart, J. Droogh, F. Ramjankhan, J. Hermens, G. Pundziute and M. Dickinson declare that they have no competing interests.